For in vitro diagnostic use. Others COC2 IVD COC2 CPS_000080 ONLINE DAT Cocaine II 08057508190 COC2, 850T, cobas c pack green COC2 07613336121153 Reagents, kits 850 tests cobas c 303/503 true 03800130190 COBAS INTEGRA COCAINE II 200 Cocaine II 04015630996537 Reagents, kits 200 tests COBAS INTEGRA 400 Plus true 06334440190 COC2, 100T, cobas c 701, 702 COC2 04015630930326 Reagents, kits 100 tests cobas c 701/702 true 04490827190 COC2, 200T, cobas c COC2 04015630997732 Reagents, kits 200 tests cobas c 311/501/502 true 08057508500 COC2 ONLINE DAT Cocaine II en 7 FF00000006EC7E0E FF0000000528A70E 08057508190 10299 cobas c 703 9493 cobas c 303 8481 cobas c 503 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useApplication in urineCocaine II (COC2) is an in vitro diagnostic test for the qualitative and semiquantitative detection of benzoylecgonine, the primary metabolite of cocaine, in human urine on cobas c systems at cutoff concentrations of 150 and 300 ng/mL. Semiquantitative test results may be obtained that permit laboratories to assess assay performance as part of a quality control program. Semiquantitative assays are intended to determine an appropriate dilution of the specimen for confirmation by a confirmatory method such as gas chromatography/mass spectrometry (GC‑MS). Cocaine II provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. GC‑MS is the preferred confirmatory method.LREFKarch SB, ed. Drug Abuse Handbook. Boca Raton, FL: CRC Press LLC 1998. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used. Application in serum and plasma**not available in all countriesCocaine II (COC2) is an in vitro diagnostic test for the qualitative detection of benzoylecgonine, the primary metabolite of cocaine, in human serum and plasma on cobas c systems at a cutoff concentration of 300 ng/mL. Cocaine II provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC‑MS) or Liquid Chromatography coupled with Tandem Mass Spectrometry (LC‑MS/MS) is the preferred confirmatory method.LREFKarch SB, ed. Drug Abuse Handbook. Boca Raton, FL: CRC Press LLC 1998. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used. en 1708057508190c503sp COC2 ONLINE DAT Cocaine II en 5 FF0000000528820E FF0000000528820E 08057508190 9493 cobas c 303 8481 cobas c 503 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useCocaine II (COCII) is an in vitro diagnostic test for the qualitative detection of benzoylecgonine, the primary metabolite of cocaine, in human serum and plasma on Roche/Hitachi cobas c systems at a cutoff concentration of 300 ng/mL.Cocaine II provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC‑MS) or Liquid Chromatography coupled with Tandem Mass Spectrometry (LC‑MS/MS) is the preferred confirmatory method.LREFKarch SB, ed. Drug Abuse Handbook. Boca Raton, FL: CRC Press LLC 1998.Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used. en 0208057508190c503 COC2 ONLINE DAT Cocaine II en 4 FF00000006B91C0E FF00000005518A0E 08057508190 9493 cobas c 303 8481 cobas c 503 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useCocaine II (COC2) is an in vitro diagnostic test for the qualitative and semiquantitative detection of benzoylecgonine, the primary metabolite of cocaine, in human urine on cobas c systems at cutoff concentrations of 150 and 300 ng/mL. Semiquantitative test results may be obtained that permit laboratories to assess assay performance as part of a quality control program. Semiquantitative assays are intended to determine an appropriate dilution of the specimen for confirmation by a confirmatory method such as gas chromatography/mass spectrometry (GC‑MS). Cocaine II provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. GC‑MS is the preferred confirmatory method.LREFKarch SB, ed. Drug Abuse Handbook. Boca Raton, FL: CRC Press LLC 1998.Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used. en 0203800130190COIN COCII ONLINE DAT Cocaine II en 8 FF0000000594D30E FF0000000594D30E 03800130190 302 COBAS INTEGRA 400 plus Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useCocaine II (COCII) is an in vitro diagnostic test intended for the semiquantitative and qualitative detection of benzoylecgonine, the primary metabolite of cocaine, in human urine at cutoff concentrations of 150 ng/mL and 300 ng/mL on COBAS INTEGRA systems. Semiquantitative test results may be obtained that permit laboratories to assess assay performance as part of a quality control program. Semiquantitative assays are intended to determine an appropriate dilution of the specimen for confirmation by a confirmatory method such as gas chromatography/mass spectrometry (GC/MS). Cocaine II provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. GC/MS is the preferred confirmatory method.LREFKarch SB, ed. Drug Abuse Handbook. Boca Raton, FL: CRC Press LLC 1998.Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used. en 06334440500 COC2 ONLINE DAT Cocaine II en 5 FF000000069F710E FF0000000075DD0E 06334440190 2492 cobas c 702 310 cobas c 701 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useCocaine II (COC2) is an in vitro diagnostic test for the qualitative and semiquantitative detection of benzoylecgonine, the primary metabolite of cocaine, in human urine on cobas c systems at cutoff concentrations of 150 and 300 ng/mL. Semiquantitative test results may be obtained that permit laboratories to assess assay performance as part of a quality control program. Semiquantitative assays are intended to determine an appropriate dilution of the specimen for confirmation by a confirmatory method such as gas chromatography/mass spectrometry (GC‑MS). Cocaine II provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. GC‑MS is the preferred confirmatory method.LREFKarch SB, ed. Drug Abuse Handbook. Boca Raton, FL: CRC Press LLC 1998. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used. en 04490827500 COC2 ONLINE DAT Cocaine II en 11 FF00000006BD870E FF00000000738C0E 04490827190 308 cobas c 311 2324 cobas c 502 309 cobas c 501 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useApplication in urineCocaine II (COC2) is an in vitro diagnostic test for the qualitative and semiquantitative detection of benzoylecgonine, the primary metabolite of cocaine, in human urine on cobas c systems at cutoff concentrations of 150 and 300 ng/mL. Semiquantitative test results may be obtained that permit laboratories to assess assay performance as part of a quality control program. Semiquantitative assays are intended to determine an appropriate dilution of the specimen for confirmation by a confirmatory method such as gas chromatography/mass spectrometry (GC‑MS). Cocaine II provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. GC‑MS is the preferred confirmatory method.LREFKarch SB, ed. Drug Abuse Handbook. Boca Raton, FL: CRC Press LLC 1998. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used. Application in serum and plasma**not available in all countriesCocaine II (COC2) is an in vitro diagnostic test for the qualitative detection of benzoylecgonine, the primary metabolite of cocaine, in human serum and plasma on cobas c systems at a cutoff concentration of 300 ng/mL. Cocaine II provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC‑MS) or Liquid Chromatography coupled with Tandem Mass Spectrometry (LC‑MS/MS) is the preferred confirmatory method.LREFKarch SB, ed. Drug Abuse Handbook. Boca Raton, FL: CRC Press LLC 1998. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used. en 0204490827190c501 COC2 ONLINE DAT Cocaine II en 11 FF00000006CB7C0E FF00000006CB7C0E 04490827190 308 cobas c 311 2324 cobas c 502 309 cobas c 501 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useCocaine II (COC2) is an in vitro diagnostic test for the qualitative and semiquantitative detection of benzoylecgonine, the primary metabolite of cocaine, in human urine on cobas c systems at cutoff concentrations of 150 and 300 ng/mL. Semiquantitative test results may be obtained that permit laboratories to assess assay performance as part of a quality control program. Semiquantitative assays are intended to determine an appropriate dilution of the specimen for confirmation by a confirmatory method such as gas chromatography/mass spectrometry (GC‑MS). Cocaine II provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. GC‑MS is the preferred confirmatory method.LREFKarch SB, ed. Drug Abuse Handbook. Boca Raton, FL: CRC Press LLC 1998.Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used. en 1704490827190c501sp COC2 ONLINE DAT Cocaine II en 4 FF00000004745F0E FF00000001D3590E 04490827190 2324 cobas c 502 309 cobas c 501 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useCocaine II (COCII) is an in vitro diagnostic test for the qualitative detection of benzoylecgonine, the primary metabolite of cocaine, in human serum and plasma on Roche/Hitachi cobas c systems at a cutoff concentration of 300 ng/mL. Cocaine II provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC‑MS) or Liquid Chromatography coupled with Tandem Mass Spectrometry (LC‑MS/MS) is the preferred confirmatory method.LREFKarch SB, ed. Drug Abuse Handbook. Boca Raton, FL: CRC Press LLC 1998. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used. en